Hey Deals
it's hard to say but there was a good reason to reinitialize conjumab program for AMD. I guess
there is some substantial interest from pharmaceutical industry, especially PFE, or ILNS has a partner, license agreement, or a possible buyer for ANTISENILIN and CONJUMAB in a package already. PFE spend billions based on ANTISENILIN, maybe I am wrong but they want the science and the patents.
ALLIMO
Things that are equal to the same thing are also equal to one another (Transitive property of equality). If equals are added to equals, then the wholes are equal. If equals are subtracted from equals, then the remainders are equal. Things that coincide wi